Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine.

PubWeight™: 1.35‹?› | Rank: Top 10%

🔗 View Article (PMC 152247)

Published in Proc Natl Acad Sci U S A on March 11, 2003

Authors

Enrique Santamaria1, Matías A Avila, M Ujue Latasa, Angel Rubio, Antonio Martin-Duce, Shelly C Lu, José M Mato, Fernando J Corrales

Author Affiliations

1: Laboratorio de Proteómica, Genómica y Bioinformática, and División de Hepatologia y Terapia Génica, Facultad de Medicina, Universidad de Navarra, 31008 Pamplona, Spain.

Articles citing this

NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol (2013) 2.20

Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic Biol Med (2008) 2.14

Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut (2005) 1.88

S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev (2012) 1.82

The Prohibitins: emerging roles in diverse functions. J Cell Mol Med (2006) 1.81

Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol (2008) 1.73

S-Adenosylmethionine in cell growth, apoptosis and liver cancer. J Gastroenterol Hepatol (2008) 1.71

Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients. J Virol (2005) 1.29

Cellular and mitochondrial effects of alcohol consumption. Int J Environ Res Public Health (2010) 1.22

Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice. Hepatology (2010) 1.19

Identification of the human mitochondrial S-adenosylmethionine transporter: bacterial expression, reconstitution, functional characterization and tissue distribution. Biochem J (2004) 1.19

Identification and functional reconstitution of yeast mitochondrial carrier for S-adenosylmethionine. EMBO J (2003) 1.16

Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury. World J Gastroenterol (2010) 1.13

Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease. J Nutr Biochem (2010) 1.03

Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World J Gastroenterol (2014) 0.99

Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process. Int J Exp Pathol (2004) 0.98

Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor-induced lethal hepatitis. J Clin Invest (2004) 0.98

Alcohol-induced S-adenosylhomocysteine accumulation in the liver sensitizes to TNF hepatotoxicity: possible involvement of mitochondrial S-adenosylmethionine transport. Biochem Pharmacol (2007) 0.98

Analysis of the liver mitochondrial proteome in response to ethanol and S-adenosylmethionine treatments: novel molecular targets of disease and hepatoprotection. Am J Physiol Gastrointest Liver Physiol (2010) 0.96

Mitochondria and redox signaling in steatohepatitis. Antioxid Redox Signal (2011) 0.96

Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications. Redox Biol (2014) 0.89

Harvest index, a parameter conditioning responsiveness of wheat plants to elevated CO2. J Exp Bot (2013) 0.87

Depletion of S-adenosyl-l-methionine with cycloleucine potentiates cytochrome P450 2E1 toxicity in primary rat hepatocytes. Arch Biochem Biophys (2007) 0.87

Low-dose methotrexate inhibits methionine S-adenosyltransferase in vitro and in vivo. Mol Med (2012) 0.84

Identification of replication-competent HSV-1 Cgal+ strain signaling targets in human hepatoma cells by functional organelle proteomics. Mol Cell Proteomics (2008) 0.84

Non-alcoholic fatty liver disease proteomics. Proteomics Clin Appl (2010) 0.83

HSV-1 Cgal+ infection promotes quaking RNA binding protein production and induces nuclear-cytoplasmic shuttling of quaking I-5 isoform in human hepatoma cells. Mol Cell Proteomics (2011) 0.82

Proteomic analysis of human hepatoma cells expressing methionine adenosyltransferase I/III: Characterization of DDX3X as a target of S-adenosylmethionine. J Proteomics (2012) 0.79

The hepatocarcinogenic effect of methionine and choline deficient diets: an adaptation to the Warburg effect? Alcohol Clin Exp Res (2011) 0.79

The methyl donor S-adenosylmethionine prevents liver hypoxia and dysregulation of mitochondrial bioenergetic function in a rat model of alcohol-induced fatty liver disease. Redox Biol (2016) 0.78

The Combination of S-adenosylmethionine and Dilinoleoylphosphatidylcholine Attenuates Non-alcoholic Steatohepatitis Produced in Rats by a High-Fat Diet. Nutr Res (2007) 0.78

A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma. Funct Integr Genomics (2011) 0.78

Systems biology for hepatologists. Hepatology (2014) 0.76

Synergistic Effects of Cilostazol and Probucol on ER Stress-Induced Hepatic Steatosis via Heme Oxygenase-1-Dependent Activation of Mitochondrial Biogenesis. Oxid Med Cell Longev (2016) 0.75

Prohibitin 1 Suppresses Liver Cancers Tumorigenesis in Mice and Human Hepatocellular and Cholangiocarcinoma cells. Hepatology (2016) 0.75

Articles cited by this

Nonalcoholic fatty liver disease. N Engl J Med (2002) 22.41

1,4-Diaminobutane (putrescine), spermidine, and spermine. Annu Rev Biochem (1976) 7.12

Nonalcoholic fatty liver disease. Gastroenterology (2002) 4.15

S-Adenosylmethionine; a new intermediate formed enzymatically from L-methionine and adenosinetriphosphate. J Biol Chem (1953) 3.16

Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J (2000) 3.08

Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci U S A (2001) 2.93

Biological methylation: selected aspects. Annu Rev Biochem (1975) 2.53

Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol (2000) 2.22

S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther (1997) 2.13

Nonalcoholic steatohepatitis. Gastroenterology (2001) 2.12

S-Adenosylmethionine: a control switch that regulates liver function. FASEB J (2002) 2.08

Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J Biol Chem (2002) 2.06

Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J (2002) 2.04

Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes. Gastroenterology (1998) 1.96

The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell Mol Life Sci (2002) 1.94

Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys (2000) 1.74

Prohibitin, an antiproliferative protein, is localized to mitochondria. FEBS Lett (1995) 1.71

Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet (1997) 1.67

Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp Cell Res (2001) 1.57

Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells. Cancer Res (1998) 1.56

Changes in S-adenosylmethionine synthetase in human liver cancer: molecular characterization and significance. Hepatology (1996) 1.56

Labile methyl group balances in the human: the role of sarcosine. Metabolism (1980) 1.34

S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology (1988) 1.31

Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development. Hepatology (1996) 1.30

Differential effect of thioacetamide on hepatic methionine adenosyltransferase expression in the rat. Hepatology (1999) 1.27

Purification and comparison of two forms of S-adenosyl-L-methionine synthetase from rat liver. Eur J Biochem (1987) 1.24

S-Adenosylmethionine synthetase from human lymphocytes. Purification and characterization. J Biol Chem (1985) 1.24

Modulation of rat liver S-adenosylmethionine synthetase activity by glutathione. J Biol Chem (1992) 1.18

Aging, cytochrome oxidase activity, and hydrogen peroxide release by mitochondria. Free Radic Biol Med (1993) 1.18

S-adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver. FASEB J (2000) 1.18

Fractionation and kinetic properties of rat liver and kidney methionine adenosyltransferase isozymes. Biochemistry (1983) 1.17

Methionine adenosyltransferase: structure and function. Pharmacol Ther (1993) 1.16

Nitric oxide inactivates rat hepatic methionine adenosyltransferase In vivo by S-nitrosylation. Hepatology (1998) 1.15

Changing patterns of transcriptional and post-transcriptional control of beta-F1-ATPase gene expression during mitochondrial biogenesis in liver. J Biol Chem (1995) 1.14

Control of the translational efficiency of beta-F1-ATPase mRNA depends on the regulation of a protein that binds the 3' untranslated region of the mRNA. Mol Cell Biol (1997) 1.13

Specific loss of the high-molecular-weight form of S-adenosyl-L-methionine synthetase in human liver cirrhosis. Hepatology (1988) 1.13

Formation, functions and regulatory importance of S-adenosyl-L-methionine. Adv Enzyme Regul (1970) 1.05

Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation: implications for MAT1A silencing during transformation. FASEB J (2000) 1.02

Multiple species of mammalian S-adenosylmethionine synthetase. Partial purification and characterization. Biochemistry (1981) 0.98

Prohibitin expression during cellular senescence of human diploid fibroblasts. Biochem Biophys Res Commun (1994) 0.96

A conserved mechanism for controlling the translation of beta-F1-ATPase mRNA between the fetal liver and cancer cells. J Biol Chem (2000) 0.94

Role of S-adenosylmethionine in two experimental models of pancreatitis. FASEB J (2002) 0.93

Hepatocyte growth factor induces MAT2A expression and histone acetylation in rat hepatocytes: role in liver regeneration. FASEB J (2001) 0.93

Steroidogenic acute regulatory (StAR) protein (p25) and prohibitin (p28) from cultured rat ovarian granulosa cells. J Reprod Fertil (1997) 0.93

Hysteretic behavior of methionine adenosyltransferase III. Methionine switches between two conformations of the enzyme with different specific activity. J Biol Chem (2000) 0.84

Expression of S-adenosylmethionine synthetase isozyme genes in regenerating rat liver after partial hepatectomy. Biochem Mol Biol Int (1996) 0.81

Hyperactive autocrine loop mediated by a NDF-related factor in neoplastic hamster embryo fibroblasts expressing an activated cph oncogene. Oncogene (1995) 0.80

Fractionation of methionine adenosyltransferase isozymes (rat liver). Methods Enzymol (1983) 0.78

Altered processing of precursor transcripts and increased levels of the subunit I of mitochondrial cytochrome c oxidase in Syrian hamster fetal cells initiated with ionizing radiation. Carcinogenesis (1997) 0.78

Regulation of human lymphocyte S-adenosylmethionine synthetase by product inhibition. Biochim Biophys Acta (1990) 0.77

Articles by these authors

Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice. Gut (2013) 3.08

Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology (2008) 2.91

Correlation between gene expression and GO semantic similarity. IEEE/ACM Trans Comput Biol Bioinform (2006) 2.53

Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res (2008) 2.41

Role of S-adenosyl-L-methionine in liver health and injury. Hepatology (2007) 2.21

The Appalachia Cancer Network: cancer control research among a rural, medically underserved population. J Rural Health (2004) 2.15

Emerging role of epigenetics in the actions of alcohol. Alcohol Clin Exp Res (2008) 2.14

S-Adenosylmethionine: a control switch that regulates liver function. FASEB J (2002) 2.08

Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J (2002) 2.04

Direct imaging of covalent bond structure in single-molecule chemical reactions. Science (2013) 1.98

Methionine metabolism and liver disease. Annu Rev Nutr (2008) 1.98

Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF. Sci Signal (2011) 1.90

MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma. J Clin Invest (2012) 1.86

S-adenosylmethionine in liver health, injury, and cancer. Physiol Rev (2012) 1.82

S-Adenosylmethionine in cell growth, apoptosis and liver cancer. J Gastroenterol Hepatol (2008) 1.71

Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation. Hepatology (2012) 1.66

S-adenosylmethionine stabilizes cystathionine beta-synthase and modulates redox capacity. Proc Natl Acad Sci U S A (2006) 1.66

Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology (2010) 1.63

Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-kappaB and AP-1. Mol Cell Biol (2005) 1.61

Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas. PLoS One (2011) 1.57

Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology (2007) 1.56

Computing the shortest elementary flux modes in genome-scale metabolic networks. Bioinformatics (2009) 1.54

SPACE: an algorithm to predict and quantify alternatively spliced isoforms using microarrays. Genome Biol (2008) 1.52

Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am J Clin Nutr (2007) 1.49

Non-alcoholic steatohepatitis and animal models: understanding the human disease. Int J Biochem Cell Biol (2008) 1.49

Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol (2005) 1.48

S-adenosylmethionine regulates cytoplasmic HuR via AMP-activated kinase. Gastroenterology (2006) 1.44

Amphiregulin: an early trigger of liver regeneration in mice. Gastroenterology (2005) 1.44

Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS One (2010) 1.44

GARBAN: genomic analysis and rapid biological annotation of cDNA microarray and proteomic data. Bioinformatics (2003) 1.43

Gene expression profile of omental adipose tissue in human obesity. FASEB J (2003) 1.42

Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat. Hepatology (2010) 1.41

Methionine adenosyltransferase II beta subunit gene expression provides a proliferative advantage in human hepatoma. Gastroenterology (2003) 1.40

CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis. Hepatology (2009) 1.40

Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis. Alcohol Clin Exp Res (2004) 1.37

A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme. Transgenic Res (2006) 1.33

Leptin's mitogenic effect in human liver cancer cells requires induction of both methionine adenosyltransferase 2A and 2beta. Hepatology (2008) 1.33

S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model. Hepatology (2009) 1.32

The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med (Maywood) (2009) 1.31

Expression pattern, regulation, and functions of methionine adenosyltransferase 2beta splicing variants in hepatoma cells. Gastroenterology (2007) 1.30

S-adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: Role of protein phosphatase 1 and Bcl-x(S). Hepatology (2004) 1.30

S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation. Hepatology (2008) 1.30

Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J Proteome Res (2010) 1.29

L-methionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells: role of S-adenosylmethionine. J Biol Chem (2003) 1.29

An in-depth and updated perspective on determinants of cervical cancer screening among central Appalachian women. Women Health (2005) 1.28

Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice. Hepatology (2008) 1.27

Betaine prevents Mallory-Denk body formation in drug-primed mice by epigenetic mechanisms. Exp Mol Pathol (2008) 1.27

Tumour necrosis factor alpha induces co-ordinated activation of rat GSH synthetic enzymes via nuclear factor kappaB and activator protein-1. Biochem J (2005) 1.24

S-adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells. Hepatology (2002) 1.24

5'-methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes. Hepatology (2004) 1.22

Methylthioadenosine. Int J Biochem Cell Biol (2004) 1.22

Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples. Proteomics Clin Appl (2010) 1.21

Joint analysis of miRNA and mRNA expression data. Brief Bioinform (2012) 1.21

Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications. Hepatology (2009) 1.20

The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. Hepatology (2008) 1.20

Changes in S-adenosylmethionine and GSH homeostasis during endotoxemia in mice. Lab Invest (2008) 1.19

Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A. FASEB J (2004) 1.19

Novel role for amphiregulin in protection from liver injury. J Biol Chem (2005) 1.19

Alcohol, cofactors and the genetics of hepatocellular carcinoma. J Gastroenterol Hepatol (2008) 1.19

Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice. Hepatology (2010) 1.19

Cloning and characterization of the human glutathione synthetase 5'-flanking region. Biochem J (2005) 1.15

Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells. Cancer Res (2006) 1.14

Alcohol, DNA methylation, and cancer. Alcohol Res (2013) 1.14